><title>REFERENCES</title><ref id="b1-0060006"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>M. P.</given-names></name><name><surname>Graham</surname><given-names>C. M.</given-names></name><name><surname>McNab</surname><given-names>F. W.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Bloch</surname><given-names>S. A.</given-names></name><name><surname>Oni</surname><given-names>T.</given-names></name><name><surname>Wilkinson</surname><given-names>K. A.</given-names></name><name><surname>Banchereau</surname><given-names>R.</given-names></name><name><surname>Skinner</surname><given-names>J.</given-names></name><name><surname>Wilkinson</surname><given-names>R. J.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title>. <source>Nature</source>
<volume>466</volume>, <fpage>973</fpage>&#x02013;<lpage>977</lpage><pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="b2-0060006"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>C. I.</given-names></name><name><surname>Graham</surname><given-names>C. M.</given-names></name><name><surname>Berry</surname><given-names>M. P.</given-names></name><name><surname>Wilkinson</surname><given-names>K. A.</given-names></name><name><surname>Oni</surname><given-names>T.</given-names></name><name><surname>Rozakeas</surname><given-names>F.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Rossello-Urgell</surname><given-names>J.</given-names></name><name><surname>Chaussabel</surname><given-names>D.</given-names></name><name><surname>Banchereau</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy</article-title>. <source>PLoS ONE</source>
<volume>7</volume>, <fpage>e46191</fpage><pub-id pub-id-type="pmid">23056259</pub-id></mixed-citation></ref><ref id="b3-0060006"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiorentino</surname><given-names>D. F.</given-names></name><name><surname>Zlotnik</surname><given-names>A.</given-names></name><name><surname>Vieira</surname><given-names>P.</given-names></name><name><surname>Mosmann</surname><given-names>T. R.</given-names></name><name><surname>Howard</surname><given-names>M.</given-names></name><name><surname>Moore</surname><given-names>K. W.</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A.</given-names></name></person-group> (<year>1991</year>). <article-title>IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells</article-title>. <source>J. Immunol.</source>
<volume>146</volume>, <fpage>3444</fpage>&#x02013;<lpage>3451</lpage><pub-id pub-id-type="pmid">1827484</pub-id></mixed-citation></ref><ref id="b4-0060006"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosmann</surname><given-names>T. R.</given-names></name><name><surname>Cherwinski</surname><given-names>H.</given-names></name><name><surname>Bond</surname><given-names>M. W.</given-names></name><name><surname>Giedlin</surname><given-names>M. A.</given-names></name><name><surname>Coffman</surname><given-names>R. L.</given-names></name></person-group> (<year>1986</year>). <article-title>Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins</article-title>. <source>J. Immunol.</source>
<volume>136</volume>, <fpage>2348</fpage>&#x02013;<lpage>2357</lpage><pub-id pub-id-type="pmid">2419430</pub-id></mixed-citation></ref><ref id="b5-0060006"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Garra</surname><given-names>A.</given-names></name><name><surname>Warren</surname><given-names>D. J.</given-names></name><name><surname>Holman</surname><given-names>M.</given-names></name><name><surname>Popham</surname><given-names>A. M.</given-names></name><name><surname>Sanderson</surname><given-names>C. J.</given-names></name><name><surname>Klaus</surname><given-names>G. G.</given-names></name></person-group> (<year>1986</year>). <article-title>Interleukin 4 (B-cell growth factor II/eosinophil differentiation factor) is a mitogen and differentiation factor for preactivated murine B lymphocytes</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>
<volume>83</volume>, <fpage>5228</fpage>&#x02013;<lpage>5232</lpage><pub-id pub-id-type="pmid">3487787</pub-id></mixed-citation></ref><ref id="b6-0060006"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanderson</surname><given-names>C. J.</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A.</given-names></name><name><surname>Warren</surname><given-names>D. J.</given-names></name><name><surname>Klaus</surname><given-names>G. G.</given-names></name></person-group> (<year>1986</year>). <article-title>Eosinophil differentiation factor also has B-cell growth factor activity: Proposed name interleukin 4</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>
<volume>83</volume>, <fpage>437</fpage>&#x02013;<lpage>440</lpage><pub-id pub-id-type="pmid">3484551</pub-id></mixed-citation></ref></